Specifically, we treated GFP-LC3-expressing NSCLC cells with NMP in combination with a widely accepted late autophagy inhibitor, bafilomycin A1 and quantified the GFP-LC3 signals. Here, MAP1LC3A is linked to non-small cell lung carcinoma.